Search - tctmd.com

Displaying 541 - 560 of 708

Sort: Relevancy | Date

Presentation TCT 2014

TCT 171: Avoidance of Major Bleeding with WATCHMAN Left Atrial Appendage Closure Compared with Long-term Oral Anticoagulation: A Pooled Analysis of Randomized Trials

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Matthew J. Price

September 15, 2014

Presentation TCT 2014

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Vivian Lee

September 15, 2014

Presentation TCT 2014

Fundamentals for Creating of a Successful Multidisciplinary LAA Occlusion Program

Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, Michael J. Rinaldi

September 15, 2014

Presentation TCT 2014

AF Ablation: Stand-Alone and in Conjunction with LAA Closure

Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, Vivek Y. Reddy

September 15, 2014

Presentation TCT 2014

LARIAT Experience in Patients Contraindicated to Anticoagulation

Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, Sameer Gafoor

September 15, 2014

Presentation TCT 2014

Transpericardial LAA Closure: Multicenter Results with the LARIAT

Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, Matthew J. Price

September 15, 2014

Presentation TCT 2014

Results with the Amplatzer Cardiac Plug (ACP)

Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, Reda Ibrahim

September 15, 2014

Presentation TCT 2014

Yes, It Is a Good Option for Most Anticoagulation Eligible Patients

Presenter: Saibal Kar

September 15, 2014

Presentation TCT 2014

No, It Should Be Limited to Patients with Absolute Anticoagulation Contraindications

Presenter: Jai-Wun Park

September 15, 2014

Presentation TCT 2014

Watchman II: PROTECT-AF/PREVAIL Meta-analysis and Implications

Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, David R. Holmes Jr.

September 15, 2014

Presentation TCT 2014

Watchman I: First Report of the 5-Year PROTECT-AF and Extended PREVAIL Results

Presenter: Shephal Doshi, Gregg W. Stone, Steven R. Bailey, Vivek Y. Reddy

September 15, 2014

Presentation TCT 2014

Current (and Future) Guidelines for Atrial Fibrillation Treatment

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Ted E. Feldman

September 15, 2014

Presentation TCT 2014

Techniques, Results, and Lessons from Surgical LAA Closure

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Subhasis Chatterjee

September 15, 2014

Presentation TCT 2014

Old and New Anticoagulants for Stroke Prevention: Benefits and Risks

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Jonathan L. Halperin

September 15, 2014

Presentation TCT 2014

Stroke, Bleeding, and Risk Scores in Atrial Fibrillation

Presenter: Josep Rodés-Cabau, Brian K. Whisenant, David Hildick-Smith, Stefan C. Bertog

September 15, 2014

Presentation TCT 2014

Putting it All Together: Anticoagulants, Rhythm Control, and LAA Closure Which Therapy for Which Patient?

Presenter: Matthew J. Price, Shephal Doshi

September 15, 2014

Presentation TCT 2014

Case #2: Transseptal Puncture for Left Atrial Appendage Closure

Presenter: Samir R. Kapadia, Saibal Kar, Ramon Quesada, Brian K. Whisenant

September 15, 2014

Presentation TCT 2014

Shifting the Treatment Paradigm with LAA Closure: Efficacy, Complications, and Future Challenges

Presenter: Matthew J. Price

September 15, 2014

Presentation TCT 2014

Percutaneous Left Atrial Access Using the Novel CorQuest HeartXs Device

Presenter: Josep Rodés-Cabau, Carlos E. Ruiz, David L. Brown, Pedro Martinez-Clark

September 14, 2014

Presentation TCT 2014

Can LAA Closure Become the New Standard for Stroke Prevention?

Presenter: Hilary Nierenberg, Julie Logan, Saibal Kar

September 14, 2014

Advertisement

TCT 171: Avoidance of Major Bleeding with WATCHMAN Left Atrial Appendage Closure Compared with Long-term Oral Anticoagulation: A Pooled Analysis of Randomized Trials

TCT 170: Cost-effectiveness Analysis of a Left Atrial Appendage Occlusion Device Compared with 7 Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

Fundamentals for Creating of a Successful Multidisciplinary LAA Occlusion Program

AF Ablation: Stand-Alone and in Conjunction with LAA Closure

LARIAT Experience in Patients Contraindicated to Anticoagulation

Transpericardial LAA Closure: Multicenter Results with the LARIAT

Results with the Amplatzer Cardiac Plug (ACP)

Yes, It Is a Good Option for Most Anticoagulation Eligible Patients

No, It Should Be Limited to Patients with Absolute Anticoagulation Contraindications

Watchman II: PROTECT-AF/PREVAIL Meta-analysis and Implications

Watchman I: First Report of the 5-Year PROTECT-AF and Extended PREVAIL Results

Current (and Future) Guidelines for Atrial Fibrillation Treatment

Techniques, Results, and Lessons from Surgical LAA Closure

Old and New Anticoagulants for Stroke Prevention: Benefits and Risks

Stroke, Bleeding, and Risk Scores in Atrial Fibrillation

Putting it All Together: Anticoagulants, Rhythm Control, and LAA Closure Which Therapy for Which Patient?

Case #2: Transseptal Puncture for Left Atrial Appendage Closure

Shifting the Treatment Paradigm with LAA Closure: Efficacy, Complications, and Future Challenges

Percutaneous Left Atrial Access Using the Novel CorQuest HeartXs Device

Can LAA Closure Become the New Standard for Stroke Prevention?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content